| Year |
Citation |
Score |
| 2012 |
Aarli JA, Gilhus NE, Lisak RP, Mantegazza R, Suzuki S. Myasthenia gravis. Autoimmune Diseases. 2011: 697575. PMID 22312479 DOI: 10.4061/2011/697575 |
0.704 |
|
| 2011 |
Gilhus NE, Owe JF, Hoff JM, Romi F, Skeie GO, Aarli JA. Myasthenia gravis: a review of available treatment approaches. Autoimmune Diseases. 2011: 847393. PMID 22007295 DOI: 10.4061/2011/847393 |
0.825 |
|
| 2009 |
Howlett WP, Vedeler CA, Nyland H, Aarli JA. Guillain‐Barré syndrome in northern Tanzania: a comparison of epidemiological and clinical findings with western Norway Acta Neurologica Scandinavica. 93: 44-49. PMID 8825272 DOI: 10.1111/J.1600-0404.1996.Tb00169.X |
0.533 |
|
| 2009 |
Grønning M, Albrektsen G, Kvåle G, Moen B, Aarli JA, Nyland H. Organic solvents and multiple sclerosis : a case-control study Acta Neurologica Scandinavica. 88: 247-250. PMID 8256566 DOI: 10.1111/J.1600-0404.1993.Tb04229.X |
0.524 |
|
| 2009 |
Gilhus NE, Aarli JA. Respiratory disease and nasal immunoglobulin concentrations in phenytoin-treated epileptic patients. Acta Neurologica Scandinavica. 63: 34-43. PMID 7468159 DOI: 10.1111/J.1600-0404.1981.Tb00746.X |
0.729 |
|
| 2009 |
Gilhus NE, Strandjord RE, Aarli JA. Salivary immunoglobulin concentrations in patients with epilepsy treated with carbamazepine Acta Neurologica Scandinavica. 62: 300-304. PMID 7468153 DOI: 10.1111/J.1600-0404.1980.Tb03040.X |
0.735 |
|
| 2009 |
Gilhus NE, Aarli JA. Effect of phenytoin on immunoglobulin concentrations in nasal secretions. Acta Pathologica Microbiologica Scandinavica Section C Immunology. 89: 63-68. PMID 7293776 DOI: 10.1111/J.1699-0463.1981.Tb02666.X |
0.724 |
|
| 2009 |
Strandjord RE, Johannessen SI, Aarli JA. Serum concentrations of immunoglobulins in patients with epilepsy treated with carbamazepine Acta Neurologica Scandinavica. 61: 260-263. PMID 6769290 DOI: 10.1111/J.1600-0404.1980.Tb01491.X |
0.401 |
|
| 2009 |
Larsen JP, Kvaale G, Riise T, Nyland H, Aarli JA. An increase in the incidence of multiple sclerosis in western Norway. Acta Neurologica Scandinavica. 70: 96-103. PMID 6333133 DOI: 10.1111/J.1600-0404.1984.Tb00809.X |
0.516 |
|
| 2009 |
Aarli JA. Myasthenia Gravis Binding Of Antibodies To Muscle Tissue Acta Neurologica Scandinavica. 46: 211-212. PMID 5457828 DOI: 10.1111/J.1600-0404.1970.Tb02192.X |
0.44 |
|
| 2009 |
Thorlacius S, Aarli JA, Jacobsen H, Halvorsen K. Plasma exchange in myasthenia gravis: clinical effect. Acta Neurologica Scandinavica. 72: 464-468. PMID 4082912 DOI: 10.1111/J.1600-0404.1985.Tb00902.X |
0.304 |
|
| 2009 |
Thorlacius S, Aarli JA. The cerebrospinal fluid in myasthenia gravis. Acta Neurologica Scandinavica. 72: 432-436. PMID 4082909 DOI: 10.1111/J.1600-0404.1985.Tb00896.X |
0.343 |
|
| 2009 |
Larsen JP, Kvaale G, Riise T, Nyland H, Aarli JA. Multiple sclerosis--more than one disease? Acta Neurologica Scandinavica. 72: 145-150. PMID 4050323 DOI: 10.1111/J.1600-0404.1985.Tb00856.X |
0.517 |
|
| 2009 |
Larsen JP, Riise T, Nyland H, Kvale G, Aarli JA. Clustering of multiple sclerosis in the county of Hordaland, Western Norway. Acta Neurologica Scandinavica. 71: 390-395. PMID 4013662 DOI: 10.1111/J.1600-0404.1985.Tb03218.X |
0.518 |
|
| 2009 |
Aarli JA, Vaernes R, Brubakk AO, Nyland H, Skeidsvoll H, Tønjum S. Central nervous dysfunction associated with deep-sea diving. Acta Neurologica Scandinavica. 71: 2-10. PMID 3976349 DOI: 10.1111/J.1600-0404.1985.Tb03159.X |
0.52 |
|
| 2009 |
Hofstad H, Ulvestad E, Gilhus NE, Matre R, Aarli JA. Myasthenia gravis muscle antibodies examined by ELISA: IgG and IgM antibodies characterize different patient subgroups. Acta Neurologica Scandinavica. 85: 233-238. PMID 1585794 DOI: 10.1111/J.1600-0404.1992.Tb04037.X |
0.845 |
|
| 2009 |
Aarli JA, Thunold S, Heimann P. Thyroiditis in myasthenia gravis. Acta Neurologica Scandinavica. 58: 121-127. PMID 707039 DOI: 10.1111/J.1600-0404.1978.Tb02869.X |
0.349 |
|
| 2009 |
Nyland H, Aarli JA. Guillain‐Barré syndrome: Demonstration of antibodies to peripheral nerve tissue Acta Neurologica Scandinavica. 58: 35-43. PMID 707033 DOI: 10.1111/J.1600-0404.1978.Tb02857.X |
0.627 |
|
| 2009 |
Haldorsen T, Aarli JA. Immunoglobulin concentrations in first-degree relatives of epileptic patients with drug-induced IgA deficiency. Acta Neurologica Scandinavica. 56: 608-612. PMID 605782 DOI: 10.1111/J.1600-0404.1977.Tb01466.X |
0.393 |
|
| 2009 |
Aarli JA, Gilhus NE, Romi F, Skeie GO. Myasthenia gravis in the elderly Aging Health. 5: 561-568. DOI: 10.2217/Ahe.09.44 |
0.763 |
|
| 2009 |
Hassel B, Gilhus NE, Aarli JA, Skogen OR. Fulminant myasthenia gravis and polymyositis after thymectomy for thymoma Acta Neurologica Scandinavica. 85: 63-65. DOI: 10.1111/j.1600-0404.1992.tb03997.x |
0.718 |
|
| 2009 |
Larsen JP, Riise T, Kvaale G, Nyland H, Aarli JA. MS in Hordaland, Western Norway: An increasing frequency of the disease Acta Neurologica Scandinavica. 69: 372-373. DOI: 10.1111/J.1600-0404.1984.Tb02524.X |
0.508 |
|
| 2009 |
Gilhus NE, Aarli JA, Janzen RWC, Otto HF, Matre R. Skeletal muscle antibodies in thymoma patients without myasthenia gravis Acta Neurologica Scandinavica. 69: 212-213. DOI: 10.1111/J.1600-0404.1984.Tb02443.X |
0.829 |
|
| 2009 |
Gilhus NE, Aarli JA, Christensson B, Matre R. Thymomas and skeletal muscle share an antigen in myasthenia gravis Acta Neurologica Scandinavica. 69: 210-211. DOI: 10.1111/J.1600-0404.1984.Tb02442.X |
0.787 |
|
| 2008 |
Aarli JA. Myasthenia gravis in the elderly Annals of the New York Academy of Sciences. 1132: 238-243. PMID 18567874 DOI: 10.1196/Annals.1405.040 |
0.502 |
|
| 2008 |
Aarli JA, Gilhus NE, Romi F, Skeie GO. Titin and ryanodine receptor antibodies and neuromuscular involvement in myasthenia gravis Future Neurology. 3: 87-92. DOI: 10.2217/14796708.3.1.87 |
0.867 |
|
| 2007 |
Keesey J, Aarli J. Something in the Blood? A history of the autoimmune hypothesis regarding myasthenia gravis. Journal of the History of the Neurosciences. 16: 395-412. PMID 17966056 DOI: 10.1080/09647040600675322 |
0.5 |
|
| 2007 |
Romi F, Aarli JA, Gilhus NE. Myasthenia gravis patients with ryanodine receptor antibodies have distinctive clinical features. European Journal of Neurology. 14: 617-620. PMID 17539937 DOI: 10.1111/J.1468-1331.2007.01785.X |
0.865 |
|
| 2007 |
Farbu E, Rekand T, Vik-Mo E, Lygren H, Gilhus NE, Aarli JA. Post-polio syndrome patients treated with intravenous immunoglobulin: a double-blinded randomized controlled pilot study. European Journal of Neurology. 14: 60-65. PMID 17222115 DOI: 10.1111/J.1468-1331.2006.01552.X |
0.723 |
|
| 2006 |
Romi F, Gilhus NE, Aarli JA. Myasthenia gravis: disease severity and prognosis. Acta Neurologica Scandinavica. 113: 24-25. PMID 16637923 DOI: 10.1111/J.1600-0404.2006.00609.X |
0.825 |
|
| 2006 |
Skeie GO, Aarli JA, Gilhus NE. Titin and ryanodine receptor antibodies in myasthenia gravis. Acta Neurologica Scandinavica. 113: 19-23. PMID 16637922 DOI: 10.1111/J.1600-0404.2006.00608.X |
0.813 |
|
| 2005 |
Romi F, Aarli JA, Gilhus NE. Seronegative myasthenia gravis: disease severity and prognosis. European Journal of Neurology. 12: 413-418. PMID 15885043 DOI: 10.1111/J.1468-1331.2005.01137.X |
0.862 |
|
| 2005 |
Romi F, Skeie GO, Gilhus NE, Aarli JA. Striational antibodies in myasthenia gravis: reactivity and possible clinical significance. Archives of Neurology. 62: 442-6. PMID 15767509 DOI: 10.1001/Archneur.62.3.442 |
0.855 |
|
| 2005 |
Romi F, Gilhus NE, Aarli JA. Myasthenia gravis: clinical, immunological, and therapeutic advances. Acta Neurologica Scandinavica. 111: 134-141. PMID 15644074 DOI: 10.1111/J.1600-0404.2005.00374.X |
0.763 |
|
| 2005 |
Romi F, Kristoffersen EK, Aarli JA, Gilhus NE. The role of complement in myasthenia gravis: serological evidence of complement consumption in vivo. Journal of Neuroimmunology. 158: 191-4. PMID 15589053 DOI: 10.1016/J.Jneuroim.2004.08.002 |
0.823 |
|
| 2004 |
Rekand T, Kõrv J, Farbu E, Roose M, Gilhus NE, Langeland N, Aarli JA. Lifestyle and late effects after poliomyelitis. A risk factor study of two populations. Acta Neurologica Scandinavica. 109: 120-125. PMID 14705974 DOI: 10.1034/J.1600-0404.2003.00186.X |
0.703 |
|
| 2004 |
Romi F, Kråkenes J, Aarli J, Tysnes O. Neuroborreliosis with Vasculitis Causing Stroke-Like Manifestations European Neurology. 51: 49-50. DOI: 10.1159/000075090 |
0.628 |
|
| 2003 |
Romi F, Gilhus NE, Varhaug JE, Myking A, Aarli JA. Disease severity and outcome in thymoma myasthenia gravis: a long-term observation study European Journal of Neurology. 10: 701-706. PMID 14641516 DOI: 10.1046/J.1468-1331.2003.00678.X |
0.84 |
|
| 2003 |
Romi F, Gilhus NE, Varhaug JE, Myking A, Skeie GO, Aarli JA. Thymectomy and antimuscle antibodies in nonthymomatous myasthenia gravis. Annals of the New York Academy of Sciences. 998: 481-90. PMID 14592917 DOI: 10.1196/Annals.1254.062 |
0.849 |
|
| 2003 |
Agius MA, Richman DP, Fairclough RH, Aarli J, Gilhus NE, Romi F. Three forms of immune myasthenia. Annals of the New York Academy of Sciences. 998: 453-6. PMID 14592914 DOI: 10.1196/Annals.1254.059 |
0.837 |
|
| 2003 |
Aarli JA, Romi F, Skeie GO, Gilhus NE. Myasthenia Gravis in Individuals over 40 Annals of the New York Academy of Sciences. 998: 424-431. PMID 14592910 DOI: 10.1196/Annals.1254.055 |
0.76 |
|
| 2003 |
Skeie GO, Romi F, Aarli JA, Bentsen PT, Gilhus NE. Pathogenesis of myositis and myasthenia associated with titin and ryanodine receptor antibodies. Annals of the New York Academy of Sciences. 998: 343-50. PMID 14592894 DOI: 10.1196/Annals.1254.039 |
0.865 |
|
| 2003 |
Jaretzki A, Aarli JA, Kaminski HJ, Phillips LH, Sanders DB. Thymectomy for myasthenia gravis: evaluation requires controlled prospective studies. The Annals of Thoracic Surgery. 76: 1-3. PMID 12842502 DOI: 10.1016/S0003-4975(03)00488-0 |
0.366 |
|
| 2003 |
Farbu E, Rekand T, Tysnes O-, Aarli JA, Gilhus NE, Vedeler CA. GM1 antibodies in post-polio syndrome and previous paralytic polio. Journal of Neuroimmunology. 139: 141-144. PMID 12799031 DOI: 10.1016/S0165-5728(03)00123-1 |
0.775 |
|
| 2003 |
Romi F, Gilhus NE, Varhaug JE, Myking A, Aarli JA. Thymectomy in nonthymoma early-onset myasthenia gravis in correlation with disease severity and muscle autoantibodies. European Neurology. 49: 210-217. PMID 12736536 DOI: 10.1159/000070185 |
0.859 |
|
| 2003 |
Rekand T, Kõrv J, Farbu E, Roose M, Gilhus NE, Langeland N, Aarli JA. Long term outcome after poliomyelitis in different health and social conditions Journal of Epidemiology and Community Health. 57: 368-372. PMID 12700222 DOI: 10.1136/Jech.57.5.368 |
0.699 |
|
| 2003 |
Jaretzki A, Aarli JA, Kaminski HJ, Phillips LH, Sanders DB. Preoperative preparation of patients with myasthenia gravis forestalls postoperative respiratory complications after thymectomy. The Annals of Thoracic Surgery. 75: 1068; author reply 1. PMID 12645760 DOI: 10.1016/S0003-4975(02)03811-0 |
0.313 |
|
| 2003 |
Skeie GO, Mygland A, Treves S, Gilhus NE, Aarli JA, Zorzato F. Ryanodine receptor antibodies in myasthenia gravis: epitope mapping and effect on calcium release in vitro. Muscle & Nerve. 27: 81-9. PMID 12508299 DOI: 10.1002/Mus.10294 |
0.768 |
|
| 2002 |
Romi F, Bø L, Skeie GO, Myking A, Aarli JA, Gilhus NE. Titin and ryanodine receptor epitopes are expressed in cortical thymoma along with costimulatory molecules. Journal of Neuroimmunology. 128: 82-9. PMID 12098514 DOI: 10.1016/S0165-5728(02)00145-5 |
0.857 |
|
| 2002 |
Rekand T, Karlsen B, Langeland N, Aarli JA. Long-term follow-up of patients with nonparalytic poliomyelitis. Archives of Physical Medicine and Rehabilitation. 83: 533-537. PMID 11932857 DOI: 10.1053/Apmr.2002.30936 |
0.349 |
|
| 2002 |
Romi F, Tysnes OB, Kråkenes J, Savoiardo M, Aarli JA, Bindoff L. Cystic dilation of Virchow-Robin spaces in the midbrain. European Neurology. 47: 186-8. PMID 11914561 DOI: 10.1159/000047982 |
0.62 |
|
| 2002 |
Romi F, Gilhus NE, Varhaug JE, Myking A, Skeie GO, Aarli JA. Thymectomy and anti-muscle autoantibodies in late-onset myasthenia gravis. European Journal of Neurology. 9: 55-61. PMID 11784377 DOI: 10.1046/J.1468-1331.2002.00352.X |
0.869 |
|
| 2001 |
Farbu E, Rekand T, Aarli JA, Gilhus NE. Polio survivors--well educated and hard working. Journal of Neurology. 248: 500-505. PMID 11499641 DOI: 10.1007/S004150170160 |
0.71 |
|
| 2001 |
Skeie GO, Lunde PK, Sejersted OM, Mygland Å, Aarli JA, Gilhus NE. Autoimmunity against the ryanodine receptor in myasthenia gravis. Acta Physiologica Scandinavica. 171: 379-384. PMID 11412151 DOI: 10.1046/J.1365-201X.2001.00841.X |
0.805 |
|
| 2001 |
Aarli JA. Titin, thymoma, and myasthenia gravis. Jama Neurology. 58: 869-870. PMID 11405799 DOI: 10.1001/Archneur.58.6.869 |
0.389 |
|
| 2001 |
Shelton GD, Skeie GO, Kass PH, Aarli JA. Titin and ryanodine receptor autoantibodies in dogs with thymoma and late-onset myasthenia gravis. Veterinary Immunology and Immunopathology. 78: 97-105. PMID 11182151 DOI: 10.1016/S0165-2427(00)00255-5 |
0.546 |
|
| 2000 |
Aarli JA. Epilepsy and the immune system. Jama Neurology. 57: 1689-1692. PMID 11115234 DOI: 10.1001/Archneur.57.12.1689 |
0.372 |
|
| 2000 |
Romi F, Skeie GO, Aarli JA, Gilhus NE. The severity of myasthenia gravis correlates with the serum concentration of titin and ryanodine receptor antibodies. Jama Neurology. 57: 1596-1600. PMID 11074791 DOI: 10.1001/Archneur.57.11.1596 |
0.867 |
|
| 2000 |
Romi F, Skeie GO, Vedeler C, Aarli JA, Zorzato F, Gilhus NE. Complement activation by titin and ryanodine receptor autoantibodies in myasthenia gravis. A study of IgG subclasses and clinical correlations. Journal of Neuroimmunology. 111: 169-76. PMID 11063835 DOI: 10.1016/S0165-5728(00)00394-5 |
0.86 |
|
| 2000 |
Romi F, Skeie GO, Aarli JA, Gilhus NE. Muscle autoantibodies in subgroups of myasthenia gravis patients. Journal of Neurology. 247: 369-375. PMID 10896269 DOI: 10.1007/S004150050604 |
0.859 |
|
| 2000 |
Mygland A, Vincent A, Newsom-Davis J, Kaminski H, Zorzato F, Agius M, Gilhus NE, Aarli JA. Autoantibodies in thymoma-associated myasthenia gravis with myositis or neuromyotonia. Archives of Neurology. 57: 527-31. PMID 10768628 DOI: 10.1001/Archneur.57.4.527 |
0.819 |
|
| 1999 |
Somnier FE, Skeie GO, Aarli JA, Trojaborg W. EMG evidence of myopathy and the occurrence of titin autoantibodies in patients with myasthenia gravis. European Journal of Neurology. 6: 555-563. PMID 10457388 DOI: 10.1046/J.1468-1331.1999.650555.X |
0.528 |
|
| 1999 |
Skeie GO, Pandey JP, Aarli JA, Gilhus NE. TNFA and TNFB polymorphisms in myasthenia gravis. Archives of Neurology. 56: 457-61. PMID 10199335 DOI: 10.1001/Archneur.56.4.457 |
0.664 |
|
| 1999 |
Aarli JA. Late-onset myasthenia gravis: a changing scene. Jama Neurology. 56: 25-27. PMID 9923757 DOI: 10.1001/Archneur.56.1.25 |
0.454 |
|
| 1998 |
Skeie GO, Lunde PK, Sejersted OM, Mygland Å, Aarli JA, Gilhus NE. Myasthenia gravis-associated ryanodine receptor antibodies inhibit binding of ryanodine to sarcoplasmic reticulum. Annals of the New York Academy of Sciences. 841: 530-533. PMID 9668288 DOI: 10.1111/J.1749-6632.1998.Tb10976.X |
0.742 |
|
| 1998 |
Agius MA, Zhu S, Aarli JA. Antirapsyn antibodies occur commonly in patients with lupus Annals of the New York Academy of Sciences. 841: 525-526. PMID 9668286 DOI: 10.1111/J.1749-6632.1998.Tb10974.X |
0.538 |
|
| 1998 |
Agius MA, Zhu S, Kirvan CA, Schafer AL, Lin MY, Fairclough RH, Oger JJF, Aziz T, Aarli JA. Rapsyn antibodies in myasthenia gravis Annals of the New York Academy of Sciences. 841: 516-521. PMID 9668284 DOI: 10.1111/J.1749-6632.1998.Tb10972.X |
0.499 |
|
| 1998 |
Aarli JA, Skeie GO, Mygland Å, Gilhus NE. Muscle Striation Antibodies in Myasthenia Gravis: Diagnostic and Functional Significance Annals of the New York Academy of Sciences. 841: 505-515. PMID 9668283 DOI: 10.1111/J.1749-6632.1998.Tb10971.X |
0.77 |
|
| 1998 |
Skeie G, Freiburg A, Kolmerer B, Labeit S, Aarli JA, Gilhus NE. Titin Transcripts in Thymomas Annals of the New York Academy of Sciences. 841: 422-426. PMID 9668270 DOI: 10.1111/J.1749-6632.1998.Tb10958.X |
0.639 |
|
| 1998 |
Lübke E, Freiburg A, Skeie GO, Kolmerer B, Labeit S, Aarli JA, Gilhus NE, Wollmann R, Wussling M, Rüegg JC, Linke WA. Striational autoantibodies in myasthenia gravis patients recognize I-band titin epitopes. Journal of Neuroimmunology. 81: 98-108. PMID 9521611 DOI: 10.1016/S0165-5728(97)00164-1 |
0.779 |
|
| 1998 |
Skeie GO, Lunde PK, Sejersted OM, Mygland Å, Aarli JA, Gilhus NE. Myasthenia gravis sera containing antiryanodine receptor antibodies inhibit binding of [3H]‐ryanodine to sacroplasmic reticulum Muscle & Nerve. 21: 329-335. PMID 9486861 DOI: 10.1002/(Sici)1097-4598(199803)21:3<329::Aid-Mus6>3.0.Co;2-C |
0.797 |
|
| 1998 |
Skeie GO, Bentsen PT, Freiburg A, Aarli JA, Gilhus NE. Cell-Mediated Immune Response Against Titin In Myasthenia Gravis : Evidence For The Involvement Of Th1 And Th2 Cells Scandinavian Journal of Immunology. 47: 76-81. PMID 9467662 DOI: 10.1046/J.1365-3083.1998.00260.X |
0.779 |
|
| 1998 |
Myking AO, Skeie GO, Varhaug JE, Andersen KS, Gilhus NE, Aarli JA. The histomorphology of the thymus in late onset, non‐thymoma myasthenia gravis European Journal of Neurology. 5: 401-405. DOI: 10.1046/J.1468-1331.1998.540401.X |
0.776 |
|
| 1997 |
Skeie GO, Aarli JA, Matre R, Freiburg A, Gilhus NE. Titin antibody positive myasthenia gravis patients have a cellular immune response against the main immunogenic region of titin. European Journal of Neurology. 4: 131-137. PMID 24283905 DOI: 10.1111/J.1468-1331.1997.Tb00318.X |
0.82 |
|
| 1997 |
Skeie GO, Pandey JP, Aarli JA, Gilhus NE. Autoimmunity to ryanodine receptor and titin in myasthenia gravis is associated with GM allotypes. Autoimmunity. 26: 111-6. PMID 9546812 DOI: 10.3109/08916939709003854 |
0.779 |
|
| 1997 |
Skeie GO, Freiburg A, Kolmerer B, Labeit S, Aarli JA, Appiah-Boadu S, Gilhus NE. Titin transcripts in thymomas. Journal of Autoimmunity. 10: 551-557. PMID 9451594 DOI: 10.1006/Jaut.1997.0162 |
0.773 |
|
| 1997 |
Voltz RD, Albrich WC, Nägele A, Schumm F, Wick M, Freiburg A, Gautel M, Thaler HT, Aarli J, Kirchner T, Hohlfeld R. Paraneoplastic myasthenia gravis: detection of anti-MGT30 (titin) antibodies predicts thymic epithelial tumor. Neurology. 49: 1454-7. PMID 9371941 DOI: 10.1212/Wnl.49.5.1454 |
0.525 |
|
| 1997 |
Aarli JA. Late onset myasthenia gravis European Journal of Neurology. 4: 203-209. DOI: 10.1111/J.1468-1331.1997.Tb00335.X |
0.47 |
|
| 1997 |
Skeie GO, Bentsen PT, Aarli JA, Gilhus NE. 4-34-10 Cell mediated immune response against titin in myasthenia gravis; evidence for the involvement of TH1 cells Journal of the Neurological Sciences. 150. DOI: 10.1016/S0022-510X(97)86128-X |
0.665 |
|
| 1996 |
Mygland A, Kuwajima G, Mikoshiba K, Tysnes OB, Aarli JA, Gilhus NE. Thymomas express epitopes shared by the ryanodine receptor. Journal of Neuroimmunology. 62: 79-83. PMID 7499495 DOI: 10.1016/0165-5728(95)00106-C |
0.778 |
|
| 1996 |
Skeie GO, Bartoccioni E, Evoli A, Aarli JA, Gilhus NE. Ryanodine receptor antibodies are associated with severe myasthenia gravis European Journal of Neurology. 3: 136-140. DOI: 10.1111/J.1468-1331.1996.Tb00205.X |
0.821 |
|
| 1995 |
Tandberg E, Larsen JP, Nessler EG, Riise T, Aarli JA. The epidemiology of Parkinson's disease in the county of Rogaland, Norway Movement Disorders. 10: 541-549. PMID 8552103 DOI: 10.1002/Mds.870100503 |
0.301 |
|
| 1995 |
Skeie GO, Mygland Á, Aarli JA, Gilhus NE. Titin antibodies in patients with late onset myasthenia gravis: clinical correlations. Autoimmunity. 20: 99-104. PMID 7578874 DOI: 10.3109/08916939509001933 |
0.818 |
|
| 1994 |
Mygland A, Aarli JA, Matre R, Gilhus NE. Ryanodine receptor antibodies related to severity of thymoma associated myasthenia gravis. Journal of Neurology, Neurosurgery, and Psychiatry. 57: 843-846. PMID 8021674 DOI: 10.1136/Jnnp.57.7.843 |
0.841 |
|
| 1994 |
Vedeler C, Ulvestad E, Nyland H, Matre R, Aarli JA. Receptors for gammaglobulin in the central and peripheral nervous system Journal of Neurology, Neurosurgery, and Psychiatry. 57: 9-10. PMID 7964862 DOI: 10.1136/Jnnp.57.Suppl.9 |
0.661 |
|
| 1994 |
Mygland A, Tysnes OB, Matre R, Aarli JA, Gilhus NE. Anti-cardiac ryanodine receptor antibodies in thymoma-associated myasthenia gravis. Autoimmunity. 17: 327-31. PMID 7948615 DOI: 10.3109/08916939409010673 |
0.832 |
|
| 1994 |
Mygland Å, Aarli JA, Gilhus NE. Anti-ryanodine receptor antibodies in thymoma-associated myasthenia gravis Neuromuscular Disorders. 4. DOI: 10.1016/0960-8966(94)90177-5 |
0.763 |
|
| 1994 |
Aarli J, Stefansson K, Gautel M, Labeit S, Mygland Å, Gilhus N. Titin is a major autoantigen in MG Neuromuscular Disorders. 4. DOI: 10.1016/0960-8966(94)90171-6 |
0.717 |
|
| 1994 |
Mygland Å, Aarli JA, Gilhus NE. Severity of thymoma-associated myasthenia gravis is related to the presence of anti-ryanodine receptor antibodies Neuromuscular Disorders. 4. DOI: 10.1016/0960-8966(94)90135-X |
0.762 |
|
| 1993 |
Gautel M, Lakey A, Barlow DP, Holmes Z, Scales S, Leonard K, Labeit S, Mygland A, Gilhus NE, Aarli JA. Titin antibodies in myasthenia gravis Identification of a major immunogenic region of titin Neurology. 43: 1581-1581. PMID 8351016 DOI: 10.1212/Wnl.43.8.1581 |
0.773 |
|
| 1993 |
Mygland A, Tysnes OB, Aarli JA, Matre R, Gilhus NE. IgG subclass distribution of ryanodine receptor autoantibodies in patients with myasthenia gravis and thymoma. Journal of Autoimmunity. 6: 507-15. PMID 8216692 DOI: 10.1006/Jaut.1993.1042 |
0.845 |
|
| 1992 |
Johannessen KA, Mygland A, Gilhus NE, Aarli J, Vik-Mo H. Left ventricular function in myasthenia gravis. The American Journal of Cardiology. 69: 129-32. PMID 1729861 DOI: 10.1016/0002-9149(92)90688-U |
0.679 |
|
| 1992 |
Riise T, Gronning M, Fernandez O, Lauer K, Midgard R, Minderhoud JM, Nyland H, Palffy G, Poser S, Aarli JA. Early prognostic factors for disability in multiple sclerosis, a European multicenter study Acta Neurologica Scandinavica. 85: 212-218. PMID 1575007 DOI: 10.1111/J.1600-0404.1992.Tb04031.X |
0.569 |
|
| 1992 |
Aarli JA, Gilhus NE, Matre R. Myasthenia gravis with thymoma is not associated with an increased incidence of non-muscle autoimmune disorders. Autoimmunity. 11: 159-162. PMID 1571478 DOI: 10.3109/08916939209035150 |
0.824 |
|
| 1992 |
Hofstad H, Gilhus NE, Matre R, Aarli JA. Non-receptor muscle antibodies in myasthenia gravis are of IgG1 and IgG4 subclasses. Autoimmunity. 12: 271-276. PMID 1391596 DOI: 10.3109/08916939209148469 |
0.846 |
|
| 1992 |
Mygland A, Tysnes OB, Aarli JA, Flood PR, Gilhus NE. Myasthenia gravis patients with a thymoma have antibodies against a high molecular weight protein in sarcoplasmic reticulum. Journal of Neuroimmunology. 37: 1-7. PMID 1372324 DOI: 10.1016/0165-5728(92)90150-J |
0.806 |
|
| 1992 |
Mygland A, Tysnes OB, Matre R, Volpe P, Aarli JA, Gilhus NE. Ryanodine receptor autoantibodies in myasthenia gravis patients with a thymoma. Annals of Neurology. 32: 589-91. PMID 1333745 DOI: 10.1002/ANA.410320419 |
0.808 |
|
| 1991 |
Grønning M, Riise T, Kvåle G, Nyland H, Larsen JP, Aarli JA. Incidence of multiple sclerosis in Hordaland, western Norway: a fluctuating pattern. Neuroepidemiology. 10: 53-61. PMID 2062418 DOI: 10.1159/000110247 |
0.518 |
|
| 1991 |
Spurkland A, Gilhus NE, Rønningen KS, Aarli JA, Vartdal F. Myasthenia gravis patients with thymus hyperplasia and myasthenia gravis patients with thymoma display different HLA associations Tissue Antigens. 37: 90-93. PMID 2057938 DOI: 10.1111/J.1399-0039.1991.Tb01851.X |
0.706 |
|
| 1991 |
Todnem K, Nyland H, Skeidsvoll H, Svihus R, Rinck P, Kambestad BK, Riise T, Aarli JA. Neurological long term consequences of deep diving. Occupational and Environmental Medicine. 48: 258-266. PMID 2025592 DOI: 10.1136/Oem.48.4.258 |
0.532 |
|
| 1991 |
Fredman P, Vedeler CA, Nyland H, Aarli JA, Svennerholm L. Antibodies in sera from patients with inflammatory demyelinating polyradiculoneuropathy react with ganglioside LM1 and sulphatide of peripheral nerve myelin. Journal of Neurology. 238: 75-79. PMID 1856740 DOI: 10.1007/Bf00315684 |
0.638 |
|
| 1991 |
Mygland Å, Aarli JA, Hofstad H, Gilhus NE. Heart muscle antibodies in myasthenia gravis. Autoimmunity. 10: 263-267. PMID 1772962 DOI: 10.3109/08916939109001899 |
0.801 |
|
| 1991 |
Mygland Å, Tysnes O, Aarli J, Flood P, Gilhus N. Myasthenia gravis patients with a thymoma have antibodies against a sarcoplasmic reticulum protein Journal of Autoimmunity. 4: xlii. DOI: 10.1016/0896-8411(91)90139-4 |
0.78 |
|
| 1991 |
Mygland A, Johannessen KA, Aarli JA, Gilhus NE. Reduced diastolic heart function in patients with myasthenia gravis Journal of Autoimmunity. 4. DOI: 10.1016/0896-8411(91)90087-S |
0.689 |
|
| 1991 |
Aarli JA, Gilhus NE, Matre R. Autoimmunity and thymus pathology in myasthenia gravis Journal of Neuroimmunology. 35: 102. DOI: 10.1016/0165-5728(91)91027-A |
0.762 |
|
| 1991 |
Hofstad H, Ulvestad E, Gilhus NE, Matre R, Aarli JA. Ig classes and IgG subclasses of non-receptor muscle antibodies in myasthenia gravis: Relationship to thymus pathology Journal of Neuroimmunology. 35: 69. DOI: 10.1016/0165-5728(91)90963-8 |
0.819 |
|
| 1990 |
Gilhus NE, Pandey JP, Gaarder PI, Aarli JA. Immunoglobulin allotypes in myasthenia gravis patients with a thymoma. Journal of Autoimmunity. 3: 299-305. PMID 2397020 DOI: 10.1016/0896-8411(90)90148-L |
0.769 |
|
| 1990 |
Aarli JA, Stefansson K, Marton LS, Wollmann RL. Patients with myasthenia gravis and thymoma have in their sera IgG autoantibodies against titin. Clinical and Experimental Immunology. 82: 284-8. PMID 2242609 DOI: 10.1111/J.1365-2249.1990.Tb05440.X |
0.58 |
|
| 1990 |
Todnem K, Nyland H, Kambestad BK, Aarli JA. Influence of occupational diving upon the nervous system: an epidemiological study. Occupational and Environmental Medicine. 47: 708-714. PMID 2171631 DOI: 10.1136/Oem.47.10.708 |
0.524 |
|
| 1989 |
Aarli JA, Gilhus NE, Thorlacius S, Johnsen HJ. Recovery from global amnesia during plasma exchange in myasthenia gravis: report of a case. Acta Neurologica Scandinavica. 80: 351-353. PMID 2816294 DOI: 10.1111/J.1600-0404.1989.Tb03892.X |
0.661 |
|
| 1989 |
Todnem K, Nyland H, Dick APK, Lind O, Svihus R, Molvær OI, Aarli JA. Immediate neurological effects of diving to a depth of 360 metres Acta Neurologica Scandinavica. 80: 333-340. PMID 2816291 DOI: 10.1111/J.1600-0404.1989.Tb03889.X |
0.516 |
|
| 1989 |
Thorlacius S, Aarli JA, Riise T, Matre R, Johnsen HJ. Associated disorders in myasthenia gravis: autoimmune diseases and their relation to thymectomy. Acta Neurologica Scandinavica. 80: 290-295. PMID 2816285 DOI: 10.1111/J.1600-0404.1989.Tb03881.X |
0.665 |
|
| 1989 |
Todnem K, Knudsen G, Riise T, Nyland H, Aarli JA. The non-linear relationship between nerve conduction velocity and skin temperature. Journal of Neurology, Neurosurgery, and Psychiatry. 52: 497-501. PMID 2738592 DOI: 10.1136/Jnnp.52.4.497 |
0.489 |
|
| 1989 |
Aarli JA, Aarli JA, Thorlacius S, Gilhus NE, Hofstad H. Abstract of the Second European Conference on Myasthenia Gravis held in Tremezzo, Italy on 12–14 June 1989CNS involvement in myasthenia gravis Journal of Autoimmunity. 2: 934-935. DOI: 10.1016/0896-8411(89)90075-9 |
0.676 |
|
| 1989 |
Hofstad H, Aarli J, Gilhus N, Hofstad H, Flood P, Tysnes O. Antibodies against sarcoplasmic reticulum in serum from patients with myasthenia gravis Journal of Autoimmunity. 2: 925-926. DOI: 10.1016/0896-8411(89)90060-7 |
0.797 |
|
| 1989 |
Gilhus NE, Gilhus N, Pandey J, Gaarder P, Aarli J. Immunoglobulin allotypes in myasthenia gravis (MG) patients with thymoma and non-receptor antibodies Journal of Autoimmunity. 2: 897. DOI: 10.1016/0896-8411(89)90017-6 |
0.803 |
|
| 1988 |
Thorlacius S, Mollnes TE, Garred P, Aarli JA, Matre R, Tönder O, Halvorsen K. Plasma exchange in myasthenia gravis: changes in serum complement and immunoglobulins. Acta Neurologica Scandinavica. 78: 221-7. PMID 3227807 DOI: 10.1111/j.1600-0404.1988.tb03650.x |
0.591 |
|
| 1988 |
Riise T, Grønning M, Aarli JA, Nyland H, Larsen JP, Edland A. Prognostic factors for life expectancy in multiple sclerosis analysed by Journal of Clinical Epidemiology. 41: 1031-1036. PMID 3193137 DOI: 10.1016/0895-4356(88)90041-8 |
0.545 |
|
| 1987 |
Aarli JA, Gilhus NE, Hofstad H. CA-antibody: an immunological marker of thymic neoplasia in myasthenia gravis? Acta Neurologica Scandinavica. 76: 55-57. PMID 3630645 DOI: 10.1111/J.1600-0404.1987.Tb03544.X |
0.786 |
|
| 1987 |
Thorlacius S, Aarli JA, Gilhus NE, Hofstad H. Muscle antibodies in the cerebrospinal fluid from patients with myasthenia gravis. Acta Neurologica Scandinavica. 75: 423-426. PMID 3630637 DOI: 10.1111/J.1600-0404.1987.Tb05472.X |
0.787 |
|
| 1987 |
Flood PR, Bjugn R, Gilhus NE, Hofstad H, Matre R, Aarli JA. The Ultrastructural Localization of Antigens for Skeletal Muscle Antibodies in Myasthenia Gravis Annals of the New York Academy of Sciences. 505: 732-734. DOI: 10.1111/J.1749-6632.1987.Tb51353.X |
0.815 |
|
| 1987 |
Gilhus NE, Hofstad H, Matre R, Aarli JA. Fcγ receptors on thymomas from patients with myasthenia gravis (MG) Journal of Neuroimmunology. 16: 62-63. DOI: 10.1016/0165-5728(87)90224-4 |
0.795 |
|
| 1986 |
Thorlacius S, Lefvert AK, Aarli JA, Gilhus NE, Halvorsen K, Hofstad H, Matre R, Tönder O. Plasma exchange in myasthenia gravis: effect on anti-AChR antibodies and other autoantibodies. Acta Neurologica Scandinavica. 74: 486-90. PMID 3825504 DOI: 10.1111/J.1600-0404.1986.Tb07875.X |
0.828 |
|
| 1986 |
Gilhus NE, Matre R, Aarli JA, Hofstad H, Thunold S. Thymic lymphoepitheliomas and skeletal muscle expressing common antigen(s). Acta Neurologica Scandinavica. 73: 428-433. PMID 2425540 DOI: 10.1111/J.1600-0404.1986.Tb03300.X |
0.838 |
|
| 1985 |
Gilhus NE, Aarli JA, Janzen RWC, Otto HF, Fasske E, Matre R. Skeletal muscle antibodies in patients with a thymic tumour but without myasthenia gravis Journal of Neuroimmunology. 8: 69-78. PMID 3998123 DOI: 10.1016/S0165-5728(85)80048-5 |
0.847 |
|
| 1985 |
Larsen JP, Aarli JA, Nyland H. Epidemiological studies on multiple sclerosis Neurology. 35: 1529-1529. DOI: 10.1212/Wnl.35.10.1529-A |
0.511 |
|
| 1984 |
Larsen JP, Aarli JA, Nyland H, Riise T. Western Norway, a high‐risk area for multiple sclerosis A prevalence/incidence study in the county of Hordaland Neurology. 34: 1202-1202. PMID 6540405 DOI: 10.1212/Wnl.34.9.1202 |
0.515 |
|
| 1984 |
Smith CIE, Aarli JA, Hammarstrom L, Persson MAA. IgG subclass distribution of myasthenia gravis thymoma‐associated antiskeletal muscle antibodies Neurology. 34: 1094-1094. PMID 6540388 DOI: 10.1212/Wnl.34.8.1094 |
0.55 |
|
| 1984 |
Hofstad H, Ohm OJ, Mørk SJ, Aarli JA. Heart disease in myasthenia gravis. Acta Neurologica Scandinavica. 70: 176-84. PMID 6507031 DOI: 10.1111/J.1600-0404.1984.Tb00817.X |
0.379 |
|
| 1984 |
Gilhus NE, Aarli JA, Christensson B, Matre R. Rabbit antiserum to a citric acid extract of human skeletal muscle staining thymomas from myasthenia gravis patients. Journal of Neuroimmunology. 7: 55-64. PMID 6389592 DOI: 10.1016/S0165-5728(84)80006-5 |
0.784 |
|
| 1984 |
Aarli JA. The diagnosis of thymoma in myasthenia gravis. Italian Journal of Neurological Sciences. 4: 393-7. PMID 6370907 DOI: 10.1007/BF02125617 |
0.457 |
|
| 1984 |
Gilhus NE, Aarli JA, Matre R. Myasthenia gravis Difference between thymoma‐associated antibodies and crossstriational skeleta1 muscle antibodies Neurology. 34: 246-246. PMID 6363971 DOI: 10.1212/Wnl.34.2.246 |
0.848 |
|
| 1983 |
Gilhus NE, Aarli JA, Matre R. Myasthenia gravis: the specificities of skeletal muscle and thymus antibodies. Acta Neurologica Scandinavica. 68: 328-336. PMID 6364682 DOI: 10.1111/J.1600-0404.1983.Tb04840.X |
0.841 |
|
| 1983 |
Smith CIE, Aarli JA, Biberfeld P, Bolme P, Christensson B, Gahrton G, Hammarström L, Lefvert A, Lönnqvist B, Matell G, Pirskanen R, Ringden O, Svanborg E. Myasthenia gravis after bone-marrow transplantation. Evidence for a donor origin. The New England Journal of Medicine. 309: 1565-1568. PMID 6361555 DOI: 10.1056/Nejm198312223092508 |
0.368 |
|
| 1983 |
Gilhus NE, Aarli JA, Matre R. Myasthenia gravis. Antibodies to skeletal muscle cell surface antigens. Journal of Neuroimmunology. 5: 239-249. PMID 6361067 DOI: 10.1016/0165-5728(83)90044-9 |
0.824 |
|
| 1982 |
Gilhus NE, Aarli JA, Thorsby E. HLA antigens in epileptic patients with drug-induced immunodeficiency International Journal of Immunopharmacology. 4: 517-520. PMID 7152760 DOI: 10.1016/0192-0561(82)90031-5 |
0.739 |
|
| 1982 |
Gilhus NE, Strandjord RE, Aarli JA. The effect of carbamazepine on serum immunoglobulin concentrations Acta Neurologica Scandinavica. 66: 172-179. PMID 7136483 DOI: 10.1111/J.1600-0404.1982.Tb04514.X |
0.722 |
|
| 1982 |
Gilhus NE, Strandjord RE, Aarli JA. Respiratory Disease in Patients with Epilepsy on Single-Drug Therapy with Carbamazepine or Phenobarbital European Neurology. 21: 284-288. PMID 7117316 DOI: 10.1159/000115493 |
0.709 |
|
| 1982 |
Gilhus NE, Matre R, Aarli JA. Lymphocyte subpopulations and lymphocyte function in phenytoin-treated patients with epilepsy. International Journal of Immunopharmacology. 4: 43-48. PMID 6979523 DOI: 10.1016/0192-0561(82)90007-8 |
0.776 |
|
| 1982 |
Tönnessen TI, Nyland H, Aarli JA. Complement factors and acute phase reactants in the Guillain-Barré syndrome. European Neurology. 21: 124-128. PMID 6920298 DOI: 10.1159/000115467 |
0.546 |
|
| 1982 |
Vedeler CA, Nyland H, Fagius J, Osterman PO, Matre R, Aarli JA, Janzen RWC, Jacobsen H, Skre H. The clinical effect and the effect on serum IgG antibodies to peripheral nerve tissue of plasma exchange in patients with Guillain-Barré syndrome Journal of Neurology. 228: 59-64. PMID 6184459 DOI: 10.1007/Bf00313410 |
0.77 |
|
| 1982 |
Gilhus NE, Matre R, Aarli JA. Alpha-fetoprotein concentrations in sera from epileptic patients with immunodeficiency. International Journal of Immunopharmacology. 4: 423-427. PMID 6182118 DOI: 10.1016/0192-0561(82)90016-9 |
0.782 |
|
| 1981 |
Aarli JA, Lefvert AK, Tönder O. Thymoma-specific antibodies in sera from patients with myasthenia gravis demonstrated by indirect haemagglutination. Journal of Neuroimmunology. 1: 421-7. PMID 7346525 DOI: 10.1016/0165-5728(81)90021-7 |
0.603 |
|
| 1981 |
Aarli JA, Thunold S. Serological Detection of Thymoma in Myasthenia Gravis European Neurology. 20: 380-387. PMID 7285988 DOI: 10.1159/000115265 |
0.461 |
|
| 1981 |
Gilhus NE, Aarli JA. The reversibility of phenytoin-induced IgA deficiency. Journal of Neurology. 226: 53-61. PMID 6181216 DOI: 10.1007/Bf00313318 |
0.728 |
|
| 1980 |
Naess A, Gilhus NE, Aarli JA. Lymphocyte subpopulations and IgG concentrations in cerebrospinal fluid and blood from patients with myasthenia gravis. Scandinavian Journal of Immunology. 11: 431-6. PMID 6966819 DOI: 10.1111/j.1365-3083.1980.tb00009.x |
0.746 |
|
| 1979 |
Fossan GO, Aarli JA. Immunoglobulin G in serum and cerebrospinal fluid from epileptic patients treated with phenytoin. European Neurology. 18: 322-7. PMID 527607 DOI: 10.1159/000115096 |
0.83 |
|
| 1979 |
Aarli JA, Heimann P, Matre R, Thunold S, Tönder O. Lymphocyte subpopulations in thymus and blood from patients with myasthenia gravis. Journal of Neurology, Neurosurgery, and Psychiatry. 42: 29-34. PMID 310870 DOI: 10.1136/Jnnp.42.1.29 |
0.562 |
|
| 1976 |
Aarli JA. Drug-induced IgA deficiency in epileptic patients. Jama Neurology. 33: 296-299. PMID 1259644 DOI: 10.1001/Archneur.1976.00500040080014 |
0.42 |
|
| 1976 |
Aarli JA, Mattsson C, Heilbronn E. Antibodies against nicotinic acetylcholine receptor and skeletal muscle in human and experimental myasthenia gravis. Scandinavian Journal of Immunology. 4: 849-52. PMID 1215840 DOI: 10.1111/j.1365-3083.1975.tb03727.x |
0.432 |
|
| 1976 |
Aarli JA. CHANGES IN SERUM IMMUNOGLOBULIN LEVELS DURING PHENYTOIN TREATMENT of EPILEPSY Acta Neurologica Scandinavica. 54: 423-430. PMID 998166 DOI: 10.1111/J.1600-0404.1976.Tb04374.X |
0.449 |
|
| 1976 |
Aarli JA. Phenytoin-induced depression of salivary IgA and gingival hyperplasia. Epilepsia. 17: 283-291. PMID 976219 DOI: 10.1111/J.1528-1157.1976.Tb03407.X |
0.386 |
|
| 1975 |
Aarli JA, Tönder O. Effect of antiepileptic drugs on serum and salivary IgA. Scandinavian Journal of Immunology. 4: 391-6. PMID 1188324 DOI: 10.1111/j.1365-3083.1975.tb02641.x |
0.327 |
|
| 1975 |
Aarli JA, Milde EJ, Thunold S. Arthritis in myasthenia gravis. Journal of Neurology, Neurosurgery, and Psychiatry. 38: 1048-1055. PMID 1107489 DOI: 10.1136/Jnnp.38.11.1048 |
0.479 |
|
| 1975 |
AARLI JA, MATTSSON C, HEILBRONN E. Antibodies Against Nicotinic Acetylcholine Receptor and Skeletal Muscle in Human and Experimental Myasthenia Gravis Scandinavian Journal of Immunology. 4: 849-852. DOI: 10.1111/j.1365-3083.1975.tb02696.x |
0.316 |
|
| 1974 |
Closs O, Aarli JA. Evans blue as counterstain in the demonstration of muscle antibodies by immunofluorescence in myasthenia gravis. Journal of Clinical Pathology. 27: 162-7. PMID 4132968 DOI: 10.1136/jcp.27.2.162 |
0.353 |
|
| 1974 |
Aarli JA, Tønder O, Closs O. Specificity of muscle antibodies in sera from patients with myasthenia gravis and from immunized rabbits Journal of Neurology, Neurosurgery, and Psychiatry. 37: 991-996. DOI: 10.1136/Jnnp.37.9.991 |
0.83 |
|
| 1972 |
Aarli JA. Localization and properties of an acid-soluble muscle antigen reacting with antibodies in myasthenia gravis sera. Acta Pathologica Et Microbiologica Scandinavica. Section B: Microbiology and Immunology. 80: 453-9. PMID 4114938 DOI: 10.1111/J.1699-0463.1972.TB00060.X |
0.37 |
|
| 1971 |
Aarli JA. Myasthenia gravis: results of serological investigations compared with clinical data. Acta Neurologica Scandinavica. 47: 594-602. PMID 5139724 DOI: 10.1111/J.1600-0404.1971.Tb07511.X |
0.512 |
|
| 1971 |
Aarli JA. Demonstration of antibodies to muscle by absorption of rheumatoid factor. Acta Pathologica Et Microbiologica Scandinavica. Section B: Microbiology and Immunology. 79: 365-71. PMID 4103940 DOI: 10.1111/J.1699-0463.1971.TB00074.X |
0.34 |
|
| Show low-probability matches. |
